These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
445 related items for PubMed ID: 15530670
1. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity. Kim SS, Han HW, Go U, Chung HW. Vaccine; 2004 Dec 02; 23(3):290-7. PubMed ID: 15530670 [Abstract] [Full Text] [Related]
2. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA. Saudi Med J; 2005 Oct 02; 26(10):1551-4. PubMed ID: 16228054 [Abstract] [Full Text] [Related]
3. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 02; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related]
4. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid]. Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A. An Esp Pediatr; 1999 May 02; 50(5):459-62. PubMed ID: 10394183 [Abstract] [Full Text] [Related]
5. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign. Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA. BMC Public Health; 2007 Jun 08; 7():99. PubMed ID: 17555601 [Abstract] [Full Text] [Related]
6. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia. Jaber SM. Saudi Med J; 2006 Jan 08; 27(1):63-9. PubMed ID: 16432596 [Abstract] [Full Text] [Related]
7. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Eur J Public Health; 2012 Feb 08; 22(1):133-9. PubMed ID: 20880991 [Abstract] [Full Text] [Related]
8. Sero-response to measles-mumps-rubella vaccine campaign in Saudi Arabia. Al-Mazrou YY, Khalil MK, Tumsah S, Al-Ghamdi YS, Al-Jeffri MH, Tischer AB, Mishkhas AA, Eissa M. Saudi Med J; 2002 Jun 08; 23(6):680-3. PubMed ID: 12070547 [Abstract] [Full Text] [Related]
9. Sustained measles elimination in Australia and priorities for long term maintenance. Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, McIntyre PB. Vaccine; 2007 May 04; 25(18):3574-80. PubMed ID: 17300858 [Abstract] [Full Text] [Related]
10. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C. Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126 [Abstract] [Full Text] [Related]
11. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100 [Abstract] [Full Text] [Related]
12. Humoral and cellular immune response after measles vaccination in Taiwan. Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL. J Microbiol Immunol Infect; 2005 Jun 01; 38(3):169-75. PubMed ID: 15986066 [Abstract] [Full Text] [Related]
13. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study. Avijgan M, Hafizi M, Moghni M, Kheiri S, Esteghamati A, Sarikhani S. East Afr J Public Health; 2011 Jun 01; 8(2):88-91. PubMed ID: 22066292 [Abstract] [Full Text] [Related]
14. The Australian Measles Control Campaign, 1998. Turnbull FM, Burgess MA, McIntyre PB, Lambert SB, Gilbert GL, Gidding HF, Escott RG, Achat HM, Hull BP, Wang H, Sam GA, Mead CL. Bull World Health Organ; 2001 Jun 01; 79(9):882-8. PubMed ID: 11584738 [Abstract] [Full Text] [Related]
15. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt? Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA. East Mediterr Health J; 2009 Jun 01; 15(1):85-93. PubMed ID: 19469430 [Abstract] [Full Text] [Related]
16. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Epidemiol Infect; 2011 Apr 01; 139(4):494-504. PubMed ID: 20587123 [Abstract] [Full Text] [Related]
17. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Bae GR, Choe YJ, Go UY, Kim YI, Lee JK. Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654 [Abstract] [Full Text] [Related]
18. Measles and mumps immunity in Northern Greece, 2004-2007. Fylaktou A, Haidopoulou K, Goutaki M, Papadimitriou E, Kalamitsiou S, Papaventsis D. Euro Surveill; 2008 Apr 17; 13(16):. PubMed ID: 18768118 [Abstract] [Full Text] [Related]
19. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Amela C, Pachón I, de Ory F. Eur J Epidemiol; 2003 Apr 17; 18(1):71-9. PubMed ID: 12705626 [Abstract] [Full Text] [Related]
20. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G. Przegl Epidemiol; 2003 Apr 17; 57(2):281-8. PubMed ID: 12910596 [Abstract] [Full Text] [Related] Page: [Next] [New Search]